European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update

BACKGROUND: A previous European Headache Federation (EHF) guideline addressed the use of monoclonal antibodies targeting the calcitonin gene-related peptide (CGRP) pathway to prevent migraine. Since then, randomized controlled trials (RCTs) and real-world evidence have expanded the evidence and know...

Descripción completa

Detalles Bibliográficos
Autores principales: Sacco, Simona, Amin, Faisal Mohammad, Ashina, Messoud, Bendtsen, Lars, Deligianni, Christina I., Gil-Gouveia, Raquel, Katsarava, Zaza, MaassenVanDenBrink, Antoinette, Martelletti, Paolo, Mitsikostas, Dimos-Dimitrios, Ornello, Raffaele, Reuter, Uwe, Sanchez-del-Rio, Margarita, Sinclair, Alexandra J., Terwindt, Gisela, Uluduz, Derya, Versijpt, Jan, Lampl, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2022
Materias:
Consensus Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188162/
https://www.ncbi.nlm.nih.gov/pubmed/35690723
http://dx.doi.org/10.1186/s10194-022-01431-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188162/
https://www.ncbi.nlm.nih.gov/pubmed/35690723
http://dx.doi.org/10.1186/s10194-022-01431-x

Ejemplares similares